<bill session="117" type="s" number="4794" updated="2022-12-29T13:03:35Z">
  <state datetime="2022-09-07">REFERRED</state>
  <status>
    <introduced datetime="2022-09-07"/>
  </status>
  <introduced datetime="2022-09-07"/>
  <titles>
    <title type="display">Naloxone Education and Access Act</title>
    <title type="short" as="introduced">Naloxone Education and Access Act</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act with respect to opioid overdose reversal medication access, education, and co-prescribing grant programs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001230"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-09-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-09-07" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-28T16:37:48Z" status="Introduced in Senate">Naloxone Education and Access Act

This bill reauthorizes through FY2027, expands eligibility for, and otherwise makes changes to a grant program that supports access to medications that reverse opioid overdoses (e.g., naloxone).</summary>
</bill>
